WWP2 overexpression inhibits the antitumor effects of doxorubicin in hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Cell Biology International"
DOI: 10.1002/cbin.11856
Abstract: Hepatocellular carcinoma (HCC) is a common liver cancer that accounts for 90% of cases. Doxorubicin exhibits a broad spectrum of antitumor activity and is one of the most active agents in HCC. WW domain‐containing protein… read more here.
Keywords: wwp2 overexpression; hepatocellular carcinoma; effects doxorubicin; wwp2 ... See more keywords